Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
63.80+1.15 (+1.84%)
At close: 04:00PM EDT
61.88 -1.92 (-3.01%)
After hours: 04:05PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close59.66
Open59.84
Bid42.42 x 1400
Ask99.93 x 800
Day's Range58.65 - 63.28
52 Week Range45.20 - 104.38
Volume454,650
Avg. Volume565,835
Market Cap4.349B
Beta (5Y Monthly)1.67
PE Ratio (TTM)N/A
EPS (TTM)-5.32
Earnings DateMay 02, 2022 - May 06, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est128.81
  • Simply Wall St.

    Ultragenyx Pharmaceutical (NASDAQ:RARE) shareholders have endured a 51% loss from investing in the stock a year ago

    Taking the occasional loss comes part and parcel with investing on the stock market. And there's no doubt that...

  • GlobeNewswire

    Ultragenyx to Present at Goldman Sachs Global Healthcare Conference

    NOVATO, Calif., June 10, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, and Mardi Dier, the company’s Chief Financial Officer, will present at the Goldman Sachs Global Healthcare Conference on Thursday, June 16, 2022, at 10:00

  • GlobeNewswire

    Ultragenyx to Present at Jefferies Global Healthcare Conference

    NOVATO, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, will present at the Jefferies Global Healthcare Conference on Wednesday, June 8, 2022, at 2:30 PM ET in New York. The live and archived webcast of the pre

Advertisement
Advertisement